Nasdaq Stock Movers On FDA Decision (RXII,ONCY, AMLN, PFE, ACUR, KG )

RXi Pharmaceuticals Corporation (Nasdaq: RXII), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi’s next generation rxRNA therapeutic platform as well as specific preclinical data generated with this platform.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

Oncolytics Biotech Inc. (Nasdaq: ONCY) announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON (exenatide for extended-release injectable suspension).

Pfizer Inc. (NYSE: PFE) announced today the discontinuation of the SUN 1170 Phase 3 open-label study of Sutent(r) (sunitinib malate) in advanced hepatocellular carcinoma, or liver cancer.

Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) and King Pharmaceuticals, Inc. (NYSE: KG) today announced that the U.S. Food and Drug Administration's(FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, Nasdaq penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.